Announcements
Sidley Represents Neomorph in Its US$100 Million Series B Financing
April 15, 2026
Sidley represented Neomorph, Inc., a biotechnology company developing innovative molecular glue degraders, in its US$100 million Series B financing. The round was led by Deerfield Management, with participation from new investors Regeneron Ventures, Longwood Fund, Alexandria Venture Investments, and Binney Street Capital. The proceeds from the financing will support Neomorph’s continued advancement of its proprietary platform and pipeline focused on discovering and developing molecular glue degraders targeting previously intractable diseases.
The Sidley team was led by Rosemary G. Reilly (Emerging Companies and Venture Capital) and included Rebecca Nauta (Emerging Companies and Venture Capital) and Matthew Dutton (Investment Funds).
Contacts
Capabilities
Suggested News & Insights
Sidley, Innovation Endeavors, and Premji Happy Hour Reception at JPMTuesday, January 12, 2027Recharge & Recaffeinate With Sidley @ JPMMonday, January 11, 2027 – Tuesday, January 12, 2027Sidley Continues Strategic Growth of Global Life Sciences Practice With Addition of Corporate Lawyers Deepa Rich and Sam ZuckerNovember 18, 2026Sidley Represents Dechra in Acquisition of Gallant PetNovember 18, 2026Sidley Represents RemeGen in Expanded US$356 Million Licensing Agreement With Vor BioNovember 16, 2026Sidley Represents Clearlake Capital Group in Mirendil’s US$1 Billion FinancingNovember 13, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory


